NCT03294109View on ClinicalTrials.gov

Evaluation of Abdominal Wall Block With Liposomal Bupivacaine for Post-Operative Analgesia in Donor Nephrectomy

PHASE4CompletedINTERVENTIONAL
Enrollment

146

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

June 24, 2020

Study Completion Date

June 24, 2020

Conditions
Pain, PostoperativeAnalgesics, OpioidAnalgesics, Non-NarcoticPhysiological Effects of DrugsPeripheral Nervous System AgentsPatient SatisfactionReturn to WorkActivity, Sexual
Interventions
DRUG

Abdominal wall block with liposomal bupivicaine

Abdominal wall block with liposomal bupivicaine

Trial Locations (1)

90095

Connie Frank Kidney Transplant Center, Los Angeles

All Listed Sponsors
lead

University of California, Los Angeles

OTHER

NCT03294109 - Evaluation of Abdominal Wall Block With Liposomal Bupivacaine for Post-Operative Analgesia in Donor Nephrectomy | Biotech Hunter | Biotech Hunter